Page last updated: 2024-08-24

capecitabine and Thymus Neoplasms

capecitabine has been researched along with Thymus Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Byron, E; Janisch, L; Salgia, R; Sharma, MR; Wood, K1
Brossart, P; Erdmann, C; Heine, A; Held, SA; Menschik, T; Schmiedel, A1
Bergaglio, M; Buonerba, C; Calabrese, F; Damiano, V; De Maio, AP; Di Lorenzo, G; Federico, P; Lalle, M; Marino, M; Merola, C; Milella, M; Montella, L; Ottaviano, M; Palmieri, G; Von Arx, C1
Bergaglio, M; Ceribelli, A; De Placido, S; Del Prete, S; Di Lorenzo, G; Federico, P; Lalle, M; Marino, M; Merola, C; Merola, G; Milella, M; Montella, L; Palmieri, G; Petillo, L1
Giaccone, G; Rajan, A1
Centeno, B; Kvols, L; Morse, B; Saranga-Perry, V; Strosberg, J1

Reviews

1 review(s) available for capecitabine and Thymus Neoplasms

ArticleYear
Chemotherapy for thymic tumors: induction, consolidation, palliation.
    Thoracic surgery clinics, 2011, Volume: 21, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Deoxycytidine; Doxorubicin; Fluorouracil; Gemcitabine; Humans; Methotrexate; Neoadjuvant Therapy; Palliative Care; Procarbazine; Thymoma; Thymus Neoplasms; Vincristine

2011

Trials

2 trial(s) available for capecitabine and Thymus Neoplasms

ArticleYear
Capecitabine plus gemcitabine in thymic epithelial tumors: final analysis of a Phase II trial.
    Future oncology (London, England), 2014, Volume: 10, Issue:14

    Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Retreatment; Thymus Neoplasms; Tomography, X-Ray Computed; Treatment Outcome

2014
Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Pilot Projects; Salvage Therapy; Survival Analysis; Thymus Neoplasms

2010

Other Studies

3 other study(ies) available for capecitabine and Thymus Neoplasms

ArticleYear
Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms.
    American journal of clinical oncology, 2018, Volume: 41, Issue:10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Celecoxib; Female; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Thymus Neoplasms

2018
Regression of liver metastases after treatment with oxaliplatin/capecitabine and development of a progressive multifocal leukoencephalopathy in a patient with advanced thymoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Apr-20, Volume: 31, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Leukoencephalopathy, Progressive Multifocal; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Remission Induction; Thymoma; Thymus Neoplasms; Treatment Outcome

2013
Treatment of metastatic neuroendocrine tumors of the thymus with capecitabine and temozolomide: a case series.
    Neuroendocrinology, 2013, Volume: 97, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Dacarbazine; Deoxycytidine; Fluorouracil; Humans; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neuroendocrine Tumors; Temozolomide; Thymus Neoplasms; Treatment Outcome

2013